Logo
  • Home
  • AI Agent
  • Annotations
  • Files
  • Pricing and plans
  • BlogAboutContact us
    APIMCP
    Terms of servicePrivacy policy
  • Get the full experience

    We save the real magic for signed-in users.

ATEC US​
HomeStock ScreenerDocument SearchChartingWatchlistsRecent Filings
Logo
  • Home
  • AI Agent
  • Annotations
  • Files
  • Pricing and plans
  • BlogAboutContact us
    APIMCP
    Terms of servicePrivacy policy
  • Get the full experience

    We save the real magic for signed-in users.

ATEC US​
HomeStock ScreenerDocument SearchChartingWatchlistsRecent Filings

Alphatec Holdings, Inc.(ATEC US)

$7.46-0.344.42%(Market Open · 17:07:27 UTC)
Ask AI
Doc SearchProfileEntity StructureFinancialsChartingShort InterestEmployees

Overview

ProfileEntity Structure

Documents

SEC Filings

Alphatec Holdings, Inc.(ATEC US)

$7.46-0.344.42%(Market Open · 17:07:27 UTC)
Ask AI
Doc SearchProfileEntity StructureFinancialsChartingShort InterestEmployees

Overview

ProfileEntity Structure

Documents

SEC Filings

Financials & Metrics

FinancialsChartingShort InterestEmployees

Financials & Metrics

FinancialsChartingShort InterestEmployees

Alphatec Holdings, Inc. — Company Profile

Alphatec Holdings, Inc. is a medical technology firm dedicated to engineering and advancing solutions for the surgical management of spinal conditions. Its product array includes the Alpha InformatiX platform, notably the SafeOp Neural InformatiX System, which is engineered to reduce the likelihood of nerve injury during surgery. For access and positioning, Alphatec offers systems such as the Sigma transforaminal lumbar interbody fusion pedicle-based access system, the Sigma PTP Access and Patient Positioning System, and the Squadron lateral retractor, all designed to optimize surgical outcomes. The company's robust line of spinal fixation devices features the Invictus Spinal Fixation System, capable of addressing various thoracolumbar pathologies, alongside its minimally invasive SingleStep System and adaptable Modular Fixation Systems, which enhance screw modularity. Further fixation options include the OsseoScrew system for spinal column restoration and the comprehensive Arsenal spinal fixation platform, catering to a spectrum of degenerative to deformity procedures. Alphatec also provides anterior lumbar plating solutions like the Aspida Anterior Lumbar Plating System for interbody fusion and the AMP Anti-Migration Plate, in addition to cervical fixation options such as the OCT Spinal Fixation System, the Trestle Luxe Anterior Cervical Plate System, and the Insignia Anterior Cervical Plate System. Its portfolio extends to interbody implants, including IdentiTi Porous Ti, Transcend Lateral, and Battalion Posterior Implants. A comprehensive suite of biologics is also available, featuring Cervical Structural Allograft Spacers, 3D ProFuse Demineralized Bone Scaffold, Neocore Osteoconductive Matrix, Alphagraft Demineralized and Cellular Bone Matrix, and Amnioshield Amniotic Tissue Barrier. The company additionally offers EOS imaging products. Alphatec Holdings markets its diverse product range throughout the United States via a network of independent distributors and its own direct sales force. Established in 1990, the company's headquarters are located in Carlsbad, California.

Sector
Industrials
Industry
Commercial Services & Supplies
Exchange
UQ
CEO
Patrick S. Miles
Headquarters
Carlsbad, CA, US
IPO Date
Jun 1, 2006
Employees
913
Website
www.atecspine.com

Key Metrics

Price
$10.03
Market Cap
$1.54B
Revenue (TTM)
$192.11M
Net Income (TTM)
$-33906000.00

Alphatec Holdings, Inc. — Company Profile

Alphatec Holdings, Inc. is a medical technology firm dedicated to engineering and advancing solutions for the surgical management of spinal conditions. Its product array includes the Alpha InformatiX platform, notably the SafeOp Neural InformatiX System, which is engineered to reduce the likelihood of nerve injury during surgery. For access and positioning, Alphatec offers systems such as the Sigma transforaminal lumbar interbody fusion pedicle-based access system, the Sigma PTP Access and Patient Positioning System, and the Squadron lateral retractor, all designed to optimize surgical outcomes. The company's robust line of spinal fixation devices features the Invictus Spinal Fixation System, capable of addressing various thoracolumbar pathologies, alongside its minimally invasive SingleStep System and adaptable Modular Fixation Systems, which enhance screw modularity. Further fixation options include the OsseoScrew system for spinal column restoration and the comprehensive Arsenal spinal fixation platform, catering to a spectrum of degenerative to deformity procedures. Alphatec also provides anterior lumbar plating solutions like the Aspida Anterior Lumbar Plating System for interbody fusion and the AMP Anti-Migration Plate, in addition to cervical fixation options such as the OCT Spinal Fixation System, the Trestle Luxe Anterior Cervical Plate System, and the Insignia Anterior Cervical Plate System. Its portfolio extends to interbody implants, including IdentiTi Porous Ti, Transcend Lateral, and Battalion Posterior Implants. A comprehensive suite of biologics is also available, featuring Cervical Structural Allograft Spacers, 3D ProFuse Demineralized Bone Scaffold, Neocore Osteoconductive Matrix, Alphagraft Demineralized and Cellular Bone Matrix, and Amnioshield Amniotic Tissue Barrier. The company additionally offers EOS imaging products. Alphatec Holdings markets its diverse product range throughout the United States via a network of independent distributors and its own direct sales force. Established in 1990, the company's headquarters are located in Carlsbad, California.

Sector
Industrials
Industry
Commercial Services & Supplies
Exchange
UQ
CEO
Patrick S. Miles
Headquarters
Carlsbad, CA, US
IPO Date
Jun 1, 2006
Employees
913
Website
www.atecspine.com

Key Metrics

Price
$10.03
Market Cap
$1.54B
Revenue (TTM)
$192.11M
Net Income (TTM)
$-33906000.00
EPS (TTM)
-0.22
P/E (TTM)
-12.30
P/B (TTM)
84.49
Dividend Yield
0.00%
ROE (TTM)
-185.73%
ROA (TTM)
-4.24%
Operating Margin
-11.48%
Beta
0.48

Dividends

Last Dividend
$0.00
Last Yield
0.00%

Summary

Alphatec Holdings, Inc. is a medical technology firm dedicated to engineering and advancing solutions for the surgical management of spinal conditions. Its product array includes the Alpha InformatiX platform, notably the SafeOp Neural InformatiX System, which is engineered to reduce the likelihood of nerve injury during surgery. For access and positioning, Alphatec offers systems such as the Sigma transforaminal lumbar interbody fusion pedicle-based access system, the Sigma PTP Access and Patient Positioning System, and the Squadron lateral retractor, all designed to optimize surgical outcomes. The company's robust line of spinal fixation devices features the Invictus Spinal Fixation System, capable of addressing various thoracolumbar pathologies, alongside its minimally invasive SingleStep System and adaptable Modular Fixation Systems, which enhance screw modularity. Further fixation options include the OsseoScrew system for spinal column restoration and the comprehensive Arsenal spinal fixation platform, catering to a spectrum of degenerative to deformity procedures. Alphatec also provides anterior lumbar plating solutions like the Aspida Anterior Lumbar Plating System for interbody fusion and the AMP Anti-Migration Plate, in addition to cervical fixation options such as the OCT Spinal Fixation System, the Trestle Luxe Anterior Cervical Plate System, and the Insignia Anterior Cervical Plate System. Its portfolio extends to interbody implants, including IdentiTi Porous Ti, Transcend Lateral, and Battalion Posterior Implants. A comprehensive suite of biologics is also available, featuring Cervical Structural Allograft Spacers, 3D ProFuse Demineralized Bone Scaffold, Neocore Osteoconductive Matrix, Alphagraft Demineralized and Cellular Bone Matrix, and Amnioshield Amniotic Tissue Barrier. The company additionally offers EOS imaging products. Alphatec Holdings markets its diverse product range throughout the United States via a network of independent distributors and its own direct sales force. Established in 1990, the company's headquarters are located in Carlsbad, California.

Website
www.atecspine.com
Location
Carlsbad, CA, US
Phone760 431 9286
Employees913
CEOPatrick S. Miles
Sector
Industrials
Industry
Commercial Services & Supplies
IPO DateJun 1, 2006

Ask AI

Company overview
Business model, segments, and competition.
Peer comparison
Metrics vs closest competitors.
Guidance & outlook
Forward guidance and assumptions.
Bull vs bear case
Upside drivers and key risks.
Valuation snapshot
Multiples vs history and peers.
Competitive moat
Defensibility and market position.
Management track record
Leadership and capital allocation history.
How it makes money
A short diagram of the business model.

Latest Documents

SEC Filings(1.6K)

Expand
  • 4Demski David M2 Nov
  • 10-QQ3ended 30 Sept 202629 Oct
  • 8-KResults of Operations and Financial Condition29 Oct
  • 4Carls Thomas Andrew5 Oct
  • 3Carls Thomas Andrew24 Sep
  • 4Miles Patrick10 Sep
  • 4Marshall Tyson Eliot7 Aug
  • 144Marshall Tyson Eliot5 Aug
  • 10-QQ2ended 30 Jun 20264 Aug
  • S-8Registration statement (employee benefit plan)4 Aug
  • 8-KResults of Operations and Financial Condition4 Aug
  • 4MCGINNIS KAREN K12 Jun
  • 4Blackford Quentin S.12 Jun
  • 4Valentine Keith12 Jun
  • 4Pelizzon David R12 Jun
  • 4Demski David M12 Jun
  • 4Berkowitz Mortimer III12 Jun
  • S-8Registration statement (employee benefit plan)11 Jun
  • 8-KDeparture of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers11 Jun
  • 144MCGINNIS KAREN K11 Jun

News

  • Alphatec Holdings (ATEC) Securities Investigation Notice - Levi & Korsinsky10:09AM
  • Alphatec: More Surgeries, Less Revenue Per Procedure03:55AM
  • Alphatec: Earnings-Related Selloff Could Provide Another Buying Opportunity5 Nov
  • Levi & Korsinsky Notifies Investors of Pending Investigation into Securities Claims Involving Alphatec Holdings (ATEC)4 Nov
  • ATEC Investors Have Opportunity to Join Alphatec Holdings, Inc. Fraud Investigation with SBS Law3 Nov
  • ATEC SHAREHOLDER INVESTIGATION: SueWallSt Notifies Investors of Potential Securities Claims Involving Alphatec Holdings2 Nov
  • Alphatec Holdings Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into Alphatec Holdings (ATEC)30 Oct
  • ATEC Shareholder Alert: Ademi LLP Investigates Claims of Securities Fraud Against Alphatec Holdings, Inc.30 Oct
  • Alphatec Plunges 32%. A Bone-Graft Slump Hits the Spine Specialist's Stock.30 Oct
  • Alphatec Holdings, Inc. (ATEC) Q3 2026 Earnings Call Transcript29 Oct
  • Alphatec Q3 Earnings Call Highlights29 Oct
  • Alphatec (ATEC) Q3 Earnings and Revenues Lag Estimates29 Oct
  • ATEC Reports Third Quarter Financial Results29 Oct
  • ATEC to Report Third Quarter 2026 Financial Results on October 29, 202619 Oct
  • Reviewing LogicMark (OTCMKTS:LGMKD) & Alphatec (NASDAQ:ATEC)1 Oct
  • Alphatec CEO Miles Patrick Purchases 115,000 Shares for $1 Million. Is the Medical Tech Stock Now a Buy?30 Sep
  • ATEC Appoints Tommy Carls Executive Vice President, Data Intelligence and Strategy23 Sep
  • Alphatec (ATEC) Moves 19.7% Higher: Will This Strength Last?14 Sep
  • Alphatec Holdings, Inc. (NASDAQ:ATEC) Receives Average Recommendation of “Moderate Buy” from Brokerages21 Aug

Mentions in Filings

  • … pproval. Changes to the Compensation Peer Group from the prior year included the removal of two companies, Shockwave Medical and Cue Healthcare, due to acquisition or bankruptcy, respectively, and the addition of <strong>Alphatec Holdings, Inc.</strong> and AtriCure, Inc. to the Compensation Peer Group, as each such company generally fit within the criteria used for fiscal 2026. The Compensation Peer Group for fiscal 2026 was approved by the Compensation Committe …
    ACCURAY INCAlphatec Holdings, Inc.·DEF 14A - Definitive proxy statement·Q2 27·16 Oct
  • … with operations in the medical device industry that Truist Securities considered generally relevant for purposes of its analysis (collectively referred to as the “selected companies”): • Advanced Medical Solutions Group plc • <strong>Alphatec Holdings, Inc.</strong> • AVITA Medical, Inc. • Integra LifeSciences Holdings Corporation • MediWound Ltd. • MiMedx Group, Inc. • Organogenesis Holdings Inc. • Tactile Systems Technology, Inc. • Vericel Corporation …
    Sanara MedTech Inc.Alphatec Holdings, Inc.·DEFM14A - PROXY STATEMENT·Q3 26·4 Sep
  • … with operations in the medical device industry that Truist Securities considered generally relevant for purposes of its analysis (collectively referred to as the “selected companies”): • Advanced Medical Solutions Group plc • <strong>Alphatec Holdings, Inc.</strong> • AVITA Medical, Inc. • Integra LifeSciences Holdings Corporation • MediWound Ltd. • MiMedx Group, Inc. • Organogenesis Holdings Inc. • Tactile Systems Technology, Inc. • Vericel Corporation …
    MIMEDX GROUP, INC.Alphatec Holdings, Inc.·424B3 - PROSPECTUS·Q3 26·4 Sep
  • <strong>Alphatec Holdings</strong> and is a Certified Public Accountant (inactive). He earned dual Bachelor of Science degrees in Accounting and Business Administration from Grace College. Since joining the Board in 2013, Ms. Saia has played an important role in supporting Align's growth and transformation as a global medical device and digital dentistry leader. Her insights and counsel have contributed to the Board's oversight of the Company's strategic priorit …
    ALIGN TECHNOLOGY INCAlphatec Holdings, Inc.·EX-99.1 - 8-K - Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers·Q3 26·31 Aug
  • … with operations in the medical device industry that Truist Securities considered generally relevant for purposes of its analysis (collectively referred to as the “selected companies”): • Advanced Medical Solutions Group plc • <strong>Alphatec Holdings, Inc.</strong> • AVITA Medical, Inc. • Integra LifeSciences Holdings Corporation • MediWound Ltd. • MiMedx Group, Inc. • Organogenesis Holdings Inc. • Tactile Systems Technology, Inc. • Vericel Corporation …
    MIMEDX GROUP, INC.Alphatec Holdings, Inc.·S-4 - REGISTRATION STATEMENT·Q3 26·24 Aug
  • … in the form of unpaid royalties relating to a number of NuVasive products. On September 13, 2022, NuVasive filed cross-claims against Dr. Pimenta for breach of contract alleging that Dr. Pimenta improperly provided inventions to <strong>Alphatec Holdings, Inc.</strong>, a competitor of NuVasive, without granting NuVasive the right of first negotiation under the Agreement. NuVasive is seeking monetary damages in the form of lost profits 26 --- Table of Contents
    GLOBUS MEDICAL INCAlphatec Holdings, Inc.·10-Q - Quarterly report Q2·Q2 26·6 Aug

Key Stats

Trading

Px/Chg 1D$10.03 / +1.31%
Prev Close$9.45
% of 52Wk H39.46%
Avg Volume3.19M
Beta0.48
Mkt Cap1.54B
FD Mkt Cap1.41B

Float

Shrs Out/Float153.79M / 121.05M
Short Float0.12%
Days to Cover3.60
Stock Repurchased$0.00

Current Valuation

EV2.03B
EV/EBITDA-1,497.60
EV/Sales2.58
P/B84.49
P/S1.96
FCF Yield-0.70%
ROE-185.73%
ROA-4.24%
Current Ratio1.90

Estimates

P/E-12.30
Est P/E0.00
Est EPS-0.01
Est PEG0.00

Valuation

Metric5Yr AvgMay '23May '24Apr '25May '26Oct '26
PRICE-BASED RATIOS
Price / Earnings-29.32-10.04-8.63-9.68-71.34-46.90
Price / Sales5.164.333.342.577.288.28
Price / Book Value53.70-43.8315.83166.3743.0387.10
Price / Free Cash Flow-3.54-11.39-9.73-11.39162.03-147.24
ENTERPRISE VALUE METRICS
Enterprise Value1,991.81,830.81,954.42,064.22,032.92,076.9
Enterprise Value / Sales6.605.224.053.389.5510.81
Enterprise Value / EBITDA-158.50-17.85-17.67-38.32518.33-1,237.00
Enterprise Value / EBIT-51.12-12.50-11.48-15.05-122.74-93.83

Financials

Full Financials
Millions USD5Yr CAGR (%)Dec '21Dec '22Dec '23Dec '24Dec '25
INCOME STATEMENT
Revenue33.1%243.2350.9482.3611.6764.2
Gross Income35.5%157.8233.1310.2424.3531.9
EBITDA-21.9%-106.9-102.6-110.6-53.9-39.7
EBIT-2.8%-137.1-146.5-170.3-137.2-122.3
Net Income5.7%-143.0-151.3-186.6-162.1-143.4
EPS (Diluted)-10.6%-1.50-1.47-1.54-1.13-0.96
BALANCE SHEET
Cash & ST Inv-3.7%187.284.7221.0138.8160.8
Total Assets8.4%572.1521.0805.2775.7791.2
Total Liabilities11.3%492.6555.6703.5766.3755.2
Total Shareholder Equity-17.9%79.4-34.7101.79.436.0
CASH FLOW
Net Operating Cash Flow—-73.3-75.1-78.5-44.745.2
Cap Ex-11.3%-68.5-58.3-87.0-93.1-42.5
Free Cash Flow—-141.9-133.4-165.5-137.82.8

Enterprise Value Bridge

Millions USD23 Oct '26
Price (As of 23 Oct '26)11.21
Basic Shares153.79
Market Cap1,723.2
Diluted Shares154.05
Fully Diluted Shares Outstanding154.05
Fully Diluted Market Cap1,726.1
+Consolidated Debt603.1
−In-the-Money Convertible Debt—
+Capital Leases29.6
+Operating Leases—
−Cash & Equivalents-139.9
−Short-term Investments-
+Total Preferred23.6
−In-the-Money Convertible Preferred—
−Investments in Unconsolidated Subs—
+Non-Controlling Interest-
+Pension Liabilities—
Enterprise Value2,210.0

Segment data

Revenue

by Products and services

  • Products And Services100%

Revenue

by Geography

  • United States94%
  • Non-us6%

Related companies

Apple Inc.

AAPL US

Kla Corp

KLAC US

Medtronic Public Limited Company

MDT US

Stryker Corp

SYK US

3M Company

MMM US

Northrop Grumman Corp /DE/

NOC US

Coherent Corp.

COHR US

Boston Scientific Corp

BSX US

Lenovo Group Ltd

LNVGY US

Garmin Ltd

GRMN US

HOYA Corporation

HOCPY US

Becton Dickinson & Co

0R19 LN

EPS (TTM)
-0.22
P/E (TTM)
-12.30
P/B (TTM)
84.49
Dividend Yield
0.00%
ROE (TTM)
-185.73%
ROA (TTM)
-4.24%
Operating Margin
-11.48%
Beta
0.48

Dividends

Last Dividend
$0.00
Last Yield
0.00%

Summary

Alphatec Holdings, Inc. is a medical technology firm dedicated to engineering and advancing solutions for the surgical management of spinal conditions. Its product array includes the Alpha InformatiX platform, notably the SafeOp Neural InformatiX System, which is engineered to reduce the likelihood of nerve injury during surgery. For access and positioning, Alphatec offers systems such as the Sigma transforaminal lumbar interbody fusion pedicle-based access system, the Sigma PTP Access and Patient Positioning System, and the Squadron lateral retractor, all designed to optimize surgical outcomes. The company's robust line of spinal fixation devices features the Invictus Spinal Fixation System, capable of addressing various thoracolumbar pathologies, alongside its minimally invasive SingleStep System and adaptable Modular Fixation Systems, which enhance screw modularity. Further fixation options include the OsseoScrew system for spinal column restoration and the comprehensive Arsenal spinal fixation platform, catering to a spectrum of degenerative to deformity procedures. Alphatec also provides anterior lumbar plating solutions like the Aspida Anterior Lumbar Plating System for interbody fusion and the AMP Anti-Migration Plate, in addition to cervical fixation options such as the OCT Spinal Fixation System, the Trestle Luxe Anterior Cervical Plate System, and the Insignia Anterior Cervical Plate System. Its portfolio extends to interbody implants, including IdentiTi Porous Ti, Transcend Lateral, and Battalion Posterior Implants. A comprehensive suite of biologics is also available, featuring Cervical Structural Allograft Spacers, 3D ProFuse Demineralized Bone Scaffold, Neocore Osteoconductive Matrix, Alphagraft Demineralized and Cellular Bone Matrix, and Amnioshield Amniotic Tissue Barrier. The company additionally offers EOS imaging products. Alphatec Holdings markets its diverse product range throughout the United States via a network of independent distributors and its own direct sales force. Established in 1990, the company's headquarters are located in Carlsbad, California.

Website
www.atecspine.com
Location
Carlsbad, CA, US
Phone760 431 9286
Employees913
CEOPatrick S. Miles
Sector
Industrials
Industry
Commercial Services & Supplies
IPO DateJun 1, 2006

Ask AI

Company overview
Business model, segments, and competition.
Peer comparison
Metrics vs closest competitors.
Guidance & outlook
Forward guidance and assumptions.
Bull vs bear case
Upside drivers and key risks.
Valuation snapshot
Multiples vs history and peers.
Competitive moat
Defensibility and market position.
Management track record
Leadership and capital allocation history.
How it makes money
A short diagram of the business model.

Latest Documents

SEC Filings(1.6K)

Expand
  • 4Demski David M2 Nov
  • 10-QQ3ended 30 Sept 202629 Oct
  • 8-KResults of Operations and Financial Condition29 Oct
  • 4Carls Thomas Andrew5 Oct
  • 3Carls Thomas Andrew24 Sep
  • 4Miles Patrick10 Sep
  • 4Marshall Tyson Eliot7 Aug
  • 144Marshall Tyson Eliot5 Aug
  • 10-QQ2ended 30 Jun 20264 Aug
  • S-8Registration statement (employee benefit plan)4 Aug
  • 8-KResults of Operations and Financial Condition4 Aug
  • 4MCGINNIS KAREN K12 Jun
  • 4Blackford Quentin S.12 Jun
  • 4Valentine Keith12 Jun
  • 4Pelizzon David R12 Jun
  • 4Demski David M12 Jun
  • 4Berkowitz Mortimer III12 Jun
  • S-8Registration statement (employee benefit plan)11 Jun
  • 8-KDeparture of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers11 Jun
  • 144MCGINNIS KAREN K11 Jun

News

  • Alphatec Holdings (ATEC) Securities Investigation Notice - Levi & Korsinsky10:09AM
  • Alphatec: More Surgeries, Less Revenue Per Procedure03:55AM
  • Alphatec: Earnings-Related Selloff Could Provide Another Buying Opportunity5 Nov
  • Levi & Korsinsky Notifies Investors of Pending Investigation into Securities Claims Involving Alphatec Holdings (ATEC)4 Nov
  • ATEC Investors Have Opportunity to Join Alphatec Holdings, Inc. Fraud Investigation with SBS Law3 Nov
  • ATEC SHAREHOLDER INVESTIGATION: SueWallSt Notifies Investors of Potential Securities Claims Involving Alphatec Holdings2 Nov
  • Alphatec Holdings Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into Alphatec Holdings (ATEC)30 Oct
  • ATEC Shareholder Alert: Ademi LLP Investigates Claims of Securities Fraud Against Alphatec Holdings, Inc.30 Oct
  • Alphatec Plunges 32%. A Bone-Graft Slump Hits the Spine Specialist's Stock.30 Oct
  • Alphatec Holdings, Inc. (ATEC) Q3 2026 Earnings Call Transcript29 Oct
  • Alphatec Q3 Earnings Call Highlights29 Oct
  • Alphatec (ATEC) Q3 Earnings and Revenues Lag Estimates29 Oct
  • ATEC Reports Third Quarter Financial Results29 Oct
  • ATEC to Report Third Quarter 2026 Financial Results on October 29, 202619 Oct
  • Reviewing LogicMark (OTCMKTS:LGMKD) & Alphatec (NASDAQ:ATEC)1 Oct
  • Alphatec CEO Miles Patrick Purchases 115,000 Shares for $1 Million. Is the Medical Tech Stock Now a Buy?30 Sep
  • ATEC Appoints Tommy Carls Executive Vice President, Data Intelligence and Strategy23 Sep
  • Alphatec (ATEC) Moves 19.7% Higher: Will This Strength Last?14 Sep
  • Alphatec Holdings, Inc. (NASDAQ:ATEC) Receives Average Recommendation of “Moderate Buy” from Brokerages21 Aug

Mentions in Filings

  • … pproval. Changes to the Compensation Peer Group from the prior year included the removal of two companies, Shockwave Medical and Cue Healthcare, due to acquisition or bankruptcy, respectively, and the addition of <strong>Alphatec Holdings, Inc.</strong> and AtriCure, Inc. to the Compensation Peer Group, as each such company generally fit within the criteria used for fiscal 2026. The Compensation Peer Group for fiscal 2026 was approved by the Compensation Committe …
    ACCURAY INCAlphatec Holdings, Inc.·DEF 14A - Definitive proxy statement·Q2 27·16 Oct
  • … with operations in the medical device industry that Truist Securities considered generally relevant for purposes of its analysis (collectively referred to as the “selected companies”): • Advanced Medical Solutions Group plc • <strong>Alphatec Holdings, Inc.</strong> • AVITA Medical, Inc. • Integra LifeSciences Holdings Corporation • MediWound Ltd. • MiMedx Group, Inc. • Organogenesis Holdings Inc. • Tactile Systems Technology, Inc. • Vericel Corporation …
    Sanara MedTech Inc.Alphatec Holdings, Inc.·DEFM14A - PROXY STATEMENT·Q3 26·4 Sep
  • … with operations in the medical device industry that Truist Securities considered generally relevant for purposes of its analysis (collectively referred to as the “selected companies”): • Advanced Medical Solutions Group plc • <strong>Alphatec Holdings, Inc.</strong> • AVITA Medical, Inc. • Integra LifeSciences Holdings Corporation • MediWound Ltd. • MiMedx Group, Inc. • Organogenesis Holdings Inc. • Tactile Systems Technology, Inc. • Vericel Corporation …
    MIMEDX GROUP, INC.Alphatec Holdings, Inc.·424B3 - PROSPECTUS·Q3 26·4 Sep
  • <strong>Alphatec Holdings</strong> and is a Certified Public Accountant (inactive). He earned dual Bachelor of Science degrees in Accounting and Business Administration from Grace College. Since joining the Board in 2013, Ms. Saia has played an important role in supporting Align's growth and transformation as a global medical device and digital dentistry leader. Her insights and counsel have contributed to the Board's oversight of the Company's strategic priorit …
    ALIGN TECHNOLOGY INCAlphatec Holdings, Inc.·EX-99.1 - 8-K - Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers·Q3 26·31 Aug
  • … with operations in the medical device industry that Truist Securities considered generally relevant for purposes of its analysis (collectively referred to as the “selected companies”): • Advanced Medical Solutions Group plc • <strong>Alphatec Holdings, Inc.</strong> • AVITA Medical, Inc. • Integra LifeSciences Holdings Corporation • MediWound Ltd. • MiMedx Group, Inc. • Organogenesis Holdings Inc. • Tactile Systems Technology, Inc. • Vericel Corporation …
    MIMEDX GROUP, INC.Alphatec Holdings, Inc.·S-4 - REGISTRATION STATEMENT·Q3 26·24 Aug
  • … in the form of unpaid royalties relating to a number of NuVasive products. On September 13, 2022, NuVasive filed cross-claims against Dr. Pimenta for breach of contract alleging that Dr. Pimenta improperly provided inventions to <strong>Alphatec Holdings, Inc.</strong>, a competitor of NuVasive, without granting NuVasive the right of first negotiation under the Agreement. NuVasive is seeking monetary damages in the form of lost profits 26 --- Table of Contents
    GLOBUS MEDICAL INCAlphatec Holdings, Inc.·10-Q - Quarterly report Q2·Q2 26·6 Aug

Key Stats

Trading

Px/Chg 1D$10.03 / +1.31%
Prev Close$9.45
% of 52Wk H39.46%
Avg Volume3.19M
Beta0.48
Mkt Cap1.54B
FD Mkt Cap1.41B

Float

Shrs Out/Float153.79M / 121.05M
Short Float0.12%
Days to Cover3.60
Stock Repurchased$0.00

Current Valuation

EV2.03B
EV/EBITDA-1,497.60
EV/Sales2.58
P/B84.49
P/S1.96
FCF Yield-0.70%
ROE-185.73%
ROA-4.24%
Current Ratio1.90

Estimates

P/E-12.30
Est P/E0.00
Est EPS-0.01
Est PEG0.00

Valuation

Metric5Yr AvgMay '23May '24Apr '25May '26Oct '26
PRICE-BASED RATIOS
Price / Earnings-29.32-10.04-8.63-9.68-71.34-46.90
Price / Sales5.164.333.342.577.288.28
Price / Book Value53.70-43.8315.83166.3743.0387.10
Price / Free Cash Flow-3.54-11.39-9.73-11.39162.03-147.24
ENTERPRISE VALUE METRICS
Enterprise Value1,991.81,830.81,954.42,064.22,032.92,076.9
Enterprise Value / Sales6.605.224.053.389.5510.81
Enterprise Value / EBITDA-158.50-17.85-17.67-38.32518.33-1,237.00
Enterprise Value / EBIT-51.12-12.50-11.48-15.05-122.74-93.83

Financials

Full Financials
Millions USD5Yr CAGR (%)Dec '21Dec '22Dec '23Dec '24Dec '25
INCOME STATEMENT
Revenue33.1%243.2350.9482.3611.6764.2
Gross Income35.5%157.8233.1310.2424.3531.9
EBITDA-21.9%-106.9-102.6-110.6-53.9-39.7
EBIT-2.8%-137.1-146.5-170.3-137.2-122.3
Net Income5.7%-143.0-151.3-186.6-162.1-143.4
EPS (Diluted)-10.6%-1.50-1.47-1.54-1.13-0.96
BALANCE SHEET
Cash & ST Inv-3.7%187.284.7221.0138.8160.8
Total Assets8.4%572.1521.0805.2775.7791.2
Total Liabilities11.3%492.6555.6703.5766.3755.2
Total Shareholder Equity-17.9%79.4-34.7101.79.436.0
CASH FLOW
Net Operating Cash Flow—-73.3-75.1-78.5-44.745.2
Cap Ex-11.3%-68.5-58.3-87.0-93.1-42.5
Free Cash Flow—-141.9-133.4-165.5-137.82.8

Enterprise Value Bridge

Millions USD23 Oct '26
Price (As of 23 Oct '26)11.21
Basic Shares153.79
Market Cap1,723.2
Diluted Shares154.05
Fully Diluted Shares Outstanding154.05
Fully Diluted Market Cap1,726.1
+Consolidated Debt603.1
−In-the-Money Convertible Debt—
+Capital Leases29.6
+Operating Leases—
−Cash & Equivalents-139.9
−Short-term Investments-
+Total Preferred23.6
−In-the-Money Convertible Preferred—
−Investments in Unconsolidated Subs—
+Non-Controlling Interest-
+Pension Liabilities—
Enterprise Value2,210.0

Segment data

Revenue

by Products and services

  • Products And Services100%

Revenue

by Geography

  • United States94%
  • Non-us6%

Related companies

Apple Inc.

AAPL US

Kla Corp

KLAC US

Medtronic Public Limited Company

MDT US

Stryker Corp

SYK US

3M Company

MMM US

Northrop Grumman Corp /DE/

NOC US

Coherent Corp.

COHR US

Boston Scientific Corp

BSX US

Lenovo Group Ltd

LNVGY US

Garmin Ltd

GRMN US

HOYA Corporation

HOCPY US

Becton Dickinson & Co

0R19 LN